Related Experiment Videos
Distal ulnar changes in children with thalassemia and deferiprone related arthropathy
Rajni Sharma1, Rama Anand, Jagdish Chandra
1Department of Pediatrics, Kalawati Saran Children's Hospital, New Delhi, India.
Insights
Deferiprone, an iron chelator for thalassemia, can cause joint issues. This study identified unique bone changes in children
Area of Science:
- Pediatric Hematology
- Pediatric Radiology
- Skeletal Dysplasias
Background:
- Thalassemia requires regular blood transfusions and iron chelation therapy.
- Deferiprone is an oral iron chelator used in thalassemia treatment.
- Deferiprone-induced arthropathy has known clinical and radiographic features, but long-term effects are unclear.
Purpose of the Study:
- To describe the long-term skeletal effects of deferiprone-related arthropathy in children with thalassemia major.
- To identify unique radiographic changes associated with deferiprone exposure.
Main Methods:
- Retrospective analysis of wrist and hand radiographs from 40 children with thalassemia.
- Evaluation of unique radiographic changes in 13 children with a history of deferiprone-related arthropathy.
- Subsequent radiographic examination of knee joints in affected children.
Main Results:
- Wrist radiographs revealed ulnar metaphyseal lucency and thinning, small ulnar epiphysis, and impaired physeal growth.
- Knee radiographs demonstrated subchondral flattening of femoral and tibial condyles with irregular articular margins.
- These findings suggest a pattern of bony dysplasia and growth disturbance.
Conclusions:
- Bony dysplasia, deformation, and impaired growth of ulnar epiphyses, metaphyses, and physes may indicate deferiprone-related arthropathy in pediatric thalassemia patients.
- These radiographic findings highlight potential long-term skeletal consequences of deferiprone treatment.
- Further research is needed to fully understand the long-term skeletal impact.
Background:
Regular blood transfusion and iron chelation are the standard of care for children with thalassemia. Deferiprone is an effective oral iron chelator but is known to cause significant arthropathy. Though clinical and radiographic features of deferiprone related arthropathy have been described, the long-term effects are not known.
Procedure:
Routine radiographs of left wrist and hand done for bone age estimation in 40 children with thalassemia were evaluated and revealed unique radiographic changes in 13 children (10 males: 3 females) with previous or current deferiprone related arthropathy. Subsequently, these children underwent radiographs of both the knee joints.
Results:
The changes on wrist X-ray included lucency and thinning of the ulnar metaphysis, small ulnar epiphysis, deformation and impaired growth of the physeal cartilage leading to reduced distance between the epiphysis and metaphysis. The knee radiograph showed subchondral flattening of femoral and tibial condyles with irregular articular margins.
Conclusions:
Bony dysplasia, deformation and impaired growth of ulnar epiphyses, metaphyses and physes may be an expression of deferiprone related arthropathy in children with thalassemia major.
Related Concept Videos
Bones of the Upper Limb: Ulna
Bones of the Upper Limb: Radius
The radius has a nail-shaped head, and a short...
Changes in the Appendicular Skeleton with Age
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Bones of the Upper Limb: Humerus
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Arteries of the Upper Limbs